ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$XENE:NASDAQ · Xenon Pharmaceuticals Inc - US

Sector: health

Conviction from: NASDAQ

52-week range: 35.6072.66

Neurology-focused biopharma (epilepsy, depression)

3 tracked filer(s) hold this · 0 opened, 1 added, 0 trimmed in 30-JUN-2026

Aggregate 13FScore 78 — mean of 3 scored holder(s) · buyers (new/add) avg 80. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7280Added +601%130,378$7,869,6160.0%
Stanley Druckenmiller / Duquesne92Holds (flat)238,600$14,4020.3%
Paul Tudor Jones / Tudor63Holds (flat)545,387$32,919,5590.0%

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.